Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Journal and Affiliations:
Nature, 11 marzo 2021
Anna De Marco, Humabs Biomed, Bellinzona
Jessica Bassi, Humabs Biomed, Bellinzona
Dora Pinto, Humabs Biomed, Bellinzona
Chiara Silacci Fregni, Humabs Biomed, Bellinzona
Siro Bianchi, Humabs Biomed, Bellinzona
Katja Culap, Humabs Biomed, Bellinzona
Stefano Jaconi, Humabs Biomed, Bellinzona
Elisabetta Cameroni, Humabs Biomed, Bellinzona
Matteo Samuele Pizzuto, Humabs Biomed, Bellinzona
Antonio Lanzavecchia, Humabs Biomed, Bellinzona
Luca Piccoli, Humabs Biomed, Bellinzona
Alessandra Franzetti Pellanda, Medicina interna e Malattie infettive, Clinica Luganese Moncucco, Lugano
Christian Garzoni, Medicina interna e Malattie infettive, Clinica Luganese Moncucco, Lugano
Davide Corti, Humabs Biomed, Bellinzona
Tags:
B1.1.7 variant
SARS-CoV-2
vaccine
Authors:
Alessandra Franzetti Pellanda
Anna De Marco
Antonio Lanzavecchia
Chiara Silacci Fregni
Christian Garzoni
Davide Corti
Dora Pinto
Elisabetta Cameroni
Jessica Bassi
Katja Culap
Luca Piccoli
Matteo Samuele Pizzuto
Siro Bianchi
Stefano Jaconi